Interaction between interferon regulatory factor 6 and glycine receptor beta shows a protective effect on developing nonsyndromic cleft lip with or without cleft palate in the Han Chinese population. Eur J Oral Sci 2019; 127: 27-32. © 2018 Eur J Oral Sci Single-nucleotide polymorphisms (SNPs) in protein-coding regions of genes which were previously reported to be associated with nonsyndromic cleft lip, with or without palate involvement (NSCL/P), were investigated. Twelve candidate loci [platelet-derived growth factor C (PDGFC), platelet-derived growth factor subunit A (PDGFA), platelet-derived growth factor receptor alpha (PDGFRA), glycine receptor alpha 2 (GLRA2), glycine receptor beta (GLRB), ATP binding cassette subfamily A member 4 (ABCA4), MAF bZIP transcription factor B (MAFB), interferon regulatory factor 6 (IRF6), CCDC26 long non-coding RNA (CCDC26), paired box 7 (PAX7), ventral anterior homeobox 1 (VAX1), and netrin 1 (NTN1)] covering 1.5 Mbp were sequenced in 136 NSCL/P patients and 54 healthy controls. Twentyfive genomic variants identified were further validated in another 400 NSCL/P and 200 controls. Two SNPs in IRF6 showed a protective effect against the development of NSCL/P (rs12405750, OR = 0.54, 95% CI: 0.41-0.69; and rs2235371, OR = 0.55, 95% CI: 0.43-0.71). The missense variant, rs2235371, alters the conserved amino acid valine to isoleucine at codon 274 (V274I). We observed that SNPs at IRF6 (rs2235371 and rs12405750) and GLRB (rs73856838 and rs72685584) show consistent interaction effects. The association between the missense SNP rs2235371 in gene IRF6 and NSCL/P suggests that this SNP may play an important role as a risk factor for NSCL/P in the Han Chinese populations. The marginal signal near 4q31 detected in previous genome-wide association studies might be caused by an interaction between the IRF6 and GLRB genes. This interaction needs to be further validated by experimentation in follow-up studies.
Oral clefts are common birth defects (14.2 per 10,000 live births) and are one of the five leading causes of perinatal deaths in China (1) . The most common subtype, nonsyndromic cleft lip with or without cleft palate (NSCL/P), accounts for more than 85% of oral clefts (1) . The aetiology of NSCL/P is complicated and attributed to a variety of environmental and genetic factors (2) . In the last two decades, several susceptibility genes and risk loci for NSCL/P have been identified by linkage analyses and genome-wide association (GWAS) studies (3) . As a result of the heterogeneity of oral clefts, only some of the associations have been replicated. Moreover, most of the genes were identified from Caucasian populations, especially in Europe and North America. More validation studies need to be carried out in the Chinese population, which has the highest prevalence among the major racial groups (4) .
In our previous study in 214 nuclear families (5), we found single-nucleotide polymorphism (SNP) rs17035464 at the promoter region of the platelet-derived growth factor C [PDGFC, (MIM: 608452)] gene, showing a parent-of-origin effect with NSCL/P. The relationship between NSCL/P and PDGFC has been reported in Chinese (6) and Filipino (7) multiplex families using whole-genome linkage analysis. However, this signal could not be replicated in GWAS (3) , which should have a higher resolution than linkage studies. We hypothesized that PDGFC might be one of the risk genes associated with the development of oral cleft specifically in Chinese and/or Asian populations. We also found ambiguous signals in two adjacent genes of PDGFC [glutamate ionotropic receptor AMPA type subunit 2 (GRIA2) and glycine receptor beta (GLRB)] in our previous work using microsatellite markers (short tandem repeats). To validate our previous findings and fine-map causal variants, we sequenced candidate genes in the PDGF gene family [PDGFC, platelet-derived growth factor subunit A (PDGFA), and platelet-derived growth factor receptor alpha (PDGFRA)] and in the neighbouring genes glycine receptor alpha 2 (GLRA2) and GLRB.
To compare the NSCL/P susceptibility gene profile of Chinese people with Caucasians, we also sequenced other statistically significant SNPs identified predominantly in European populations, including ATP binding cassette subfamily A member 4 (ABCA4), MAF bZIP transcription factor B (MAFB), interferon regulatory factor 6 (IRF6), CCDC26 long non-coding RNA (CCDC26), paired box 7 (PAX7), ventral anterior homeobox 1 (VAX1), and netrin 1 (NTN1). In the first step of this study, we performed deep sequencing of selected genes for exons, splice junctions, conserved non-coding segments, and promoter regions in a Han Chinese sample of 136 NSCL/P patients and 54 healthy controls (Table 1) . Next, 25 recognized genetic risk factors were further genotyped in a validation cohort of 400 NSCL/P patients and 200 controls from China.
Material and methods
In this study, we designed a two-step strategy to locate risk variants for NSCL/P. The study design is outlined in Fig. 1 . First of all, we sequenced candidate genes in a discovery cohort, including 136 NSCL/P patients and 54 healthy controls, to identify risk SNP/single-nucleotide variants (SNP/ SNVs; Table 1 ). Candidate genes were selected from literature review and findings in our previous study (5) . Studies published in PubMed (https://www.ncbi.nlm.nih.gov/ pubmed) during 2005-2015 on genetic risk of NSCL/P were reviewed to identify candidate loci. First, 12 candidate loci (PDGFC, PDGFA, PDGFRA, GLRA2, GLRB, ABCA4, MAFB, IRF6, CCDC26, PAX7, VAX1, and NTN1) were selected (Table 2) . Second, candidate SNP/SNVs identified at the first step were genotyped in an independent sample of 400 NSCL/P patients and 200 controls.
Study population
Blood samples were collected from NSCL/P patients who had surgery at the CL/P Treatment Centre, Plastic Surgery Hospital, Chinese Academy of Medical Sciences, from 2005 to 2012. Diagnosis of NSCL/P was confirmed by at least two specialists. Patients were excluded if he/she was a relative of an enrolled patient or refused to sign the inform consent. Healthy controls were randomly selected from outpatients without any birth defects who visited the same hospital between 2013 and 2014.
In the discovery cohort, 136 NSCL/P patients with clefts involving the lip and alveolus (except minimal cleft lip) and clefts involving the lip and palate were included (8) . To validate identified variants, genotyping was carried out in another set of 400 NSCL/P patients, regardless of degree of severity of the defect. Ethics approval for this study was given by the Ethical Institutional Committee of the Plastic Surgery Hospital, Chinese Academy of Medical Sciences. All participants provided written informed consent.
Targeted genomic regions sequencing
DNA was collected using a QIAamp DNA blood mini kit (Qiagen, Venlo, the Netherlands). Targeted genomic regions were enriched using NIMBLEGEN SEQCAP (Roche, Basel, Switzerland). The sequences of exons, splice junctions, conservative non-coding segments, and promoter regions (5 0 , 5,000 bp) for the candidate genes (PDGFC, PDGFA, PDGFRA, GLRA2, GLRB, ABCA4, MAFB, IRF6, CCDC26, PAX7, VAX1, and NTN1) were captured. Details of the selected regions are listed in Table 2 .
Samples from the 136 NSCL/P patients and 54 controls were sequenced in the first step. Every 9-10 samples were pooled for enrichment of the DNA (the median concentration of the sample before pooling was 97 ng ll À1 , range: 32-390 ng ll À1 ). In total, 14 pooled case samples and six pooled control samples were sequenced using Illumina HiSeq 2500 platform (Illumina, San Diego, CA, USA) with + 3009 coverage of targeted regions. Sequences were aligned to the reference genome (GRCh37.p13) using BWA v0.5.9 (9). Single-nucleotide variants and inset/ deletions (Indels) calls were performed using the GATK UnifiedGenotyper (GENOMEANALYSISTK-3.1-1) (10). The identified variants were annotated using SEATTLESEQ (11) . Table 1 The two-stage study design Genotyping of 25 risk SNP/SNVs identified from the 12 candidate genes ABCA4, ATP binding cassette subfamily A member 4; CCDC26, CCDC26 long non-coding RNA; GLRA2, glycine receptor alpha 2; GLRB, glycine receptor beta; IRF6, interferon regulatory factor 6; MAFB, MAF bZIP transcription factor B; NSCL/P, nonsyndromic cleft lip with or without cleft palate; NTN1, netrin 1; PAX7, paired box 7; PDGFA, platelet-derived growth factor subunit A; PDGFC, platelet-derived growth factor C; PDGFRA, platelet-derived growth factor receptor alpha; SNP/SNVs, single-nucleotide polymorphism/single-nucleotide variants; VAX1, ventral anterior homeobox 1.
Genotyping of candidate risk variants
To validate the 25 candidate variants (listed in Table S1 ) identified from deep sequencing, genotyping was performed in 400 NSCL/P cases and 200 controls on the Sequenom MassARRAY iPLEX platform (Sequenom, San Diego, CA, USA).
Statistical methods
Heterozygous SNVs with low frequency might be missed by conventional variant calling methods when multiple samples are pooled in one lane for sequencing. To avoid this, a modified variant calling approach was adopted. The allele frequency in each pooled sample was normalized Fig. 1 . In a first step, we sequenced 12 candidate genes per region in the discovery cohort. In a second step, candidate single-nucleotide polymorphism/single-nucleotide variants (SNP/SNVs) identified at the first step were genotyped in the validation cohort. ABCA4, ATP binding cassette subfamily A member 4; CCDC26, CCDC26 long non-coding RNA; GLRA2, glycine receptor alpha 2; GLRB, glycine receptor beta; IRF6, interferon regulatory factor 6; MAFB, MAF bZIP transcription factor B; NSCL/P, nonsyndromic cleft lip with or without cleft palate; NTN1, netrin 1; PAX7, paired box 7; PDGFA, platelet-derived growth factor subunit A; PDGFC, platelet-derived growth factor C; PDGFRA, platelet-derived growth factor receptor alpha; VAX1, ventral anterior homeobox 1. Table 2 Sequenced genes/regions (including exons, splice junctions, conservative non-coding segments, and promoter regions) ABCA4, ATP binding cassette subfamily A member 4; CCDC26, CCDC26 long non-coding RNA; GLRB, glycine receptor beta; GRIA2, glutamate ionotropic receptor AMPA type subunit 2; IRF6, interferon regulatory factor 6; MAFB, MAF bZIP transcription factor B; NTN1, netrin 1; PAX7, paired box 7; PDGFA, platelet-derived growth factor subunit A; PDGFC, platelet-derived growth factor C; PDGFRA, platelet-derived growth factor receptor alpha; VAX1, ventral anterior homeobox 1.
according to the total number of reads (library size). Association between identified variants and NSCL/P was tested using the chi-square test under an additive genetic model. Then, the allele and genotype frequencies were estimated, and tests for Hardy-Weinberg equilibrium (HWE) were carried out. Association analyses were conducted using PLINK v1.07 (12) . The OR and 95% CI of each variant were calculated. We corrected for multiple tests using BENJAMINI & HOCHBERG's false discovery rate (FDR) (13) . The multiplicative interaction between each pairs of SNPs was tested in the logistic model framework.
The population attributable fraction is the proportion of the hypothetical total load of disease that could be prevented by exposure to the particular risk factor assuming a simple causal model. The formula is P e 9 (1 À RR) where P e is the prevalence of the exposure and RR is the relative risk of disease as a result of that exposure. Because this is a case-control study, the OR was used as an estimate of the RR.
Results
Targeted regions of 14 pooled case samples (136 NSCL/P individual) and six pooled control samples (54 healthy controls) were sequenced in a first step of deep sequencing. In total, 28,180 variants were detected in the targeted regions with 200 kb extension in both directions. Variants with low coverage (<2009) were filtered out. Variants with multi-alleles were removed. After quality control, there were 7,432 variants available for analysis. Using tests based on a chi-square, 1,224 variants were nominally associated with NSCL/P (Table S2 ). After annotation, 25 functional variants, including missense variants or variants located in transcription factor binding sites (TFBS)/conserved regions in introns/untranslated regions (UTRs), were selected (Table S1) .
Association with IRF6 and interaction with GLRB
The 25 candidate SNP/SNVs identified in the first step of deep sequencing were genotyped in an additional sample set with 400 NSCL/Ps and 200 healthy controls. The polymorphism of 19 out of 25 SNP/SNVs were confirmed ( Table 3 ). The other six loci genotyped were monomorphic in the larger sample and were excluded. All of these 19 SNP/SNVs were in HWE. Five SNPs were statistically associated with risk of NSCL/P (P < 0.05, chi-square test). The SNPs rs2282710 in PAX7, rs66515264 in ABCA4, and rs2412556 in PDGFA were associated with increased risk of NSCL/P before multiple test correction. After multiple test correction, only two SNPs (rs12405750 and rs2235371) in IRF6 were statistically associated with decreased risk of NSCL/P (rs12405750, adjusted P = 3.6 9 10 À5 , OR = 0.54, 95% CI: 0.41-0.69; rs2235371, adjusted P = 4.78 9 10 À5 , OR = 0.55, 95% CI: 0.43-0.71). These two SNPs were in very high linkage disequilibrium (r 2 = 0.972). We performed pairwise SNP-SNP interaction analyses (Table S3) , and found evidence of statistical interaction between rs12405750 and two SNPs located in GLRB (rs73856838 and rs72685584, P < 0.05, Table 4 ).
The frequency of genotype TT of rs2235371 in this population was 0.12, lower than the frequency reported in the 1000 Genomes Project CHB (Han Chinese in Table 3 Validation of risk variants in 400 nonsyndromic cleft lip with or without cleft palate (NSCL/P) patients and 200 controls ABCA4, ATP binding cassette subfamily A member 4; GLRB, glycine receptor beta; IRF6, interferon regulatory factor 6; MAF, minor allele frequency; NTN1, netrin 1; PAX7, paired box 7; PDGFC, platelet-derived growth factor C; PDGFRA, platelet-derived growth factor receptor alpha A; SNP, single-nucleotide polymorphism.
Beijing, China) population (0.214) which had a limited sample size (103 samples) (14) . Under a recessive model, people who carry genotype TT of rs2235371 had a lower risk of NSCL/P compared with those carrying genotypes CC and CT. The OR was 0.35 (P = 2.763e-05). The crude population prevented fraction among Chinese Han was estimated as 7.7% (see Table S4 for more details).
Discussion
Deep targeted next-generation sequencing (NGS) provides an effective and cost-effective approach to detect functional genetic variants in selected genes from genome-wide linkage and/or association studies. Whole exome sequencing is not only costlier, but also has a higher false-positive rate (Type I errors). In this study: (i) we identified functional genetic variants associated with risk of NSCL/P in candidate genes, building on results from previous studies; and (ii) further validated the association in a larger and independent case-control sample. The missense variant (rs2235371) in IRF6 was statistically associated with risk of NSCL/P (adjusted P = 4.78 9 10 À5 ). In this variant, the conserved amino acid valine has been changed to isoleucine at codon 274 (V274I) in the protein-binding domain [i.e. the Smadinterferon regulatory factor binding domain (SMIR)] of IRF6 (15) . People who carry the TT homozygous genotype have a lower risk of developing NSCL/P compared with the general population. The V274I change has a protective effect against NSCL/P (OR = 0.55, adjusted P = 4.78 9 10 À5 , 95% CI: 0.43-0.71). This finding is consistent with a published study of various ethnic groups (16), meta-analyses (17, 18) , and a GWAS study in another Chinese population (19) . Another NSCL/P-associated SNP, rs12405750, is an intronic variant in IRF6, which is in high linkage disequilibrium with rs2235371.
The PDGFC gene is known to be associated with risk of oral clefts; Pdgfc knockout mice showed a cleft face phenotype (20, 21) , indicating an important role of PDGFC in the fusion of the palate shelf during embryonic development. Also, a study in zebrafish demonstrated that Pdgf signalling was negatively regulated by binding of microRNA MIR140 to the Pdgfra 3 0 UTR during palatal development (22) . CHOI et al. (23) reported that the PDGFC regulatory region SNP, rs28999109, is associated with risk of CL/P. The association between NSCL/P with genes in the PDGF family was not replicated in the current study. However, we observed SNPs at IRF6 (rs2235371 and rs12405750) and GLRB (rs73856838 and rs72685584), showing consistent evidence of interaction ( Table 4 ). The gene GLRB is adjacent to PDGFC, indicating that the marginal signal near gene PDGFC, detected in our previous study, might be a result of some interaction effect between genes IRF6 and GLRB. This interaction needs to be further explored by experimentation in a followup study.
In this study, we performed targeted sequencing on 12 previously reported candidate genes for NSCL/P risk in a Han Chinese case-control sample. Significant functional variants were further validated in another case-control sample comprising 400 NSCL/P cases and 200 healthy controls. We found that the association between NSCL/P and the missense SNP, rs2235371, in IRF6 may play an important role in controlling risk of NSCL/P in the Han Chinese population. 
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